In the cell, proteins are synthesized from N-to C-terminus and begin to fold during translation. Co-translational folding mechanisms are therefore linked to elongation rate, which varies as a function of synonymous codon usage. However, synonymous codon substitutions can affect many distinct cellular processes, which has complicated attempts to deconvolve the extent to which synonymous codon usage promotes or frustrates proper protein folding in vivo. Although previous studies have shown that some synonymous changes can lead to different final structures, other substitutions will likely be more subtle, perturbing only the protein folding pathway without altering the final structure. Here we show that synonymous codon substitutions encoding a single essential enzyme lead to dramatically slower cell growth. These mutations do not prevent active enzyme formation but instead alter the folding mechanism, leading to enhanced degradation. These results support a model where synonymous codon substitutions can impair cell fitness by altering co-translational protein folding mechanisms. Synonymous codons changes can therefore have a significant impact on fitness even when the native structure is preserved.
Introduction
Synonymous codon substitutions alter the mRNA coding sequence but preserve the encoded amino acid sequence. For this reason, these substitutions were historically considered to be phenotypically silent and often disregarded in studies of human genetic variation [1, 2] . In recent years, however, it has become clear that synonymous substitutions can significantly alter protein function in vivo, through a wide variety of mechanisms that can change protein level [3] [4] [5] , translational accuracy [6, 7] , secretion efficiency [8, 9] , the final folded structure [1, [10] [11] [12] and post-translational modifications [13] . The full range of synonymous codon effects on protein production is, however, still emerging and much remains to be learned regarding the precise mechanisms that regulate these effects.
One mechanism that has long been proposed but has scant evidence to support its significance in vivo is the extent to which synonymous codon substitutions can perturb cotranslational folding mechanisms. In general, rare synonymous codons tend to be translated more slowly than their common counterparts [14] [15] [16] [17] . Moreover, rare synonymous codons tend to appear in clusters, creating broader patterns of codon usage [18] , many of which are conserved through evolution [19] [20] [21] . The folding rates of many protein secondary and tertiary structural elements are similar to their rate of synthesis [22, 23] , lending conceptual support to the hypothesis that even subtle changes in elongation rate could alter folding mechanisms [24] . In theory, reducing the rate of translation elongation by synonymous common-to-rare codon substitutions could provide the N-terminal portion of a nascent protein with more time to adopt a stable tertiary structure before C-terminal portions are synthesized and emerge from the ribosome exit tunnel [25] [26] [27] . Depending on the specific native structure of the encoded protein, such extra time could be either advantageous or detrimental to efficient folding [28] . However, cells contain an extensive network of molecular chaperones to facilitate the folding of challenging protein structures, including several that associate with nascent polypeptide chains during translation [29] [30] [31] [32] . Thus, it remains unclear whether a synonymous codon-derived alteration to elongation rate and co-translational folding mechanism could be sufficiently perturbative to rise above the buffering provided by the cellular chaperone network.
Here we show that position-specific synonymous codon changes in the coding sequence of an enzyme essential for E. coli growth can have a dramatic impact on growth rate. We tested a variety of mechanistic origins for this growth defect, including changes to the folded protein structure, expression level, enzymatic activity, mRNA abundance and/or activation of a cell stress response. Our results are consistent with synonymous substitutions altering the cotranslational folding mechanism, leading to the formation of intermediates that are more susceptible to post-translational degradation. These results demonstrate that changes to synonymous codon usage can significantly affect protein folding in vivo and therefore have broad implications for both protein design and the interpretation of disease-associated synonymous mutations.
Results

Synonymous codon substitutions impair E. coli growth rate
To develop a system to test connections between synonymous codon usage, cotranslational folding and cell fitness, we used chloramphenicol acetyltransferase (CAT), a watersoluble, homotrimeric E. coli enzyme with a complex tertiary structure [33] (Fig. 1 ). An early study showed that synonymous codon substitutions near the middle of the coding sequence ( Fig. 2a) led to lower specific activity for CAT synthesized by in vitro translation [11] . CAT is essential for E. coli growth in chloramphenicol (cam) [34] , enabling us to use growth rate in the presence of cam as a convenient fitness assay. Furthermore, because CAT is not part of an operon or regulatory network, we hypothesized that it would be unlikely for feedback regulation of other genes to mask the effects of CAT synonymous codon changes on enzyme function [35] . Crucially, although CAT cannot be refolded to its native structure after dilution from chemical denaturants, the native structure is resistant to unfolding up to 80ºC ( Fig. S1) , highlighting the crucial role of in vivo folding intermediates on attainment of the native CAT structure.
We transformed E. coli with a plasmid encoding the previously described synonymous CAT coding sequence variant [11] under a titratable promoter but detected no discernable difference in growth versus E. coli producing CAT from the wild type (WT) coding sequence ( Fig. 2b, S2a ). Compared to WT-CAT, this synonymous construct contains a larger number of common codons ( Fig. 2a) , which leads to increased protein accumulation in vitro due to an overall faster translation elongation rate [11, 16, 25] . Consistent with these in vitro results, we detected more CAT in E. coli transformed with the coding sequence enriched in common codons ( Fig. 2c ). We hypothesized that this higher intracellular CAT concentration could mask a defect in specific activity. To test this, we used a Monte Carlo simulation method [18, 36] (see Supplemental Methods) to design and select an alternative synonymous CAT coding sequence, Shuf1, which we predicted would be more likely to produce a WT-like amount of CAT. In the Shuf1 coding sequence, the local synonymous codon usage patterns are very different from WT but the global codon usage frequencies are very similar ( Fig. 2a, S3 ). To avoid known effects of 5' synonymous codon substitutions on translation initiation [5, [37] [38] [39] [40] , the first 46 codons of Shuf1 are identical to the WT coding sequence. E. coli produced CAT from the Shuf1 coding sequence at levels indistinguishable from WT-CAT (Figure 2c ) but exhibited a significantly slower growth rate ( Fig. S2a) .
We hypothesized that we could further exacerbate the Shuf1-CAT growth defect by adapting a strategy developed by Hilvert and coworkers to couple subtle changes in enzyme function to E. coli growth rate [41] . This strategy involves encoding an ssrA tag at the Cterminus of the protein of interest, selectively enhancing its degradation by the protease ClpXP and leading to correspondingly lower intracellular protein concentrations. The smaller number of remaining enzymes face increased selective pressure to be highly functional. Addition of the ssrA tag did not affect CAT structure, stability or specific activity ( Fig. S2b-d) but did lead to a dramatic growth defect for E. coli expressing Shuf1-CAT, versus the ssrA-tagged WT CAT coding sequence, in the presence of cam ( Fig. 2b) . This defect also led to a lower minimum inhibitory concentration for E. coli expressing Shuf1-versus WT-CAT ( Fig. S2e) .
Shuf1 CAT mRNA, protein not toxic
A major challenge of all in vivo experiments is discerning the precise origin of an observed effect. For example, a recent study showed that synonymous codon substitutions can lead to toxicity at the mRNA level even in the absence of protein production [42] . To test whether production of Shuf1-CAT mRNA and/or protein is inherently toxic, we compared growth rates of E. coli expressing WT or Shuf1-CAT in the absence of cam. These growth rates were indistinguishable ( Fig. 2d) , indicating that the Shuf1 defect is specifically related to impaired CAT enzyme function. Moreover, in the presence of cam the growth defect was partially suppressed at higher inducer concentrations ( Fig. 2b) , contrary to the larger growth defect expected if the Shuf1-CAT mRNA and/or protein were inherently toxic.
To test whether Shuf1-CAT induces a cell stress response, we used mass spectrometry to compare the abundances of 1277 proteins in E. coli expressing ssrA-tagged CAT from either the WT or Shuf1 coding sequence. There was no significant difference detected in the level of most proteins, including known stress-associated molecular chaperones and proteases ( Fig.  3a) . Taken together, these results support a model where the Shuf1-CAT growth defect is due to a direct loss of CAT protein activity, rather than an indirect effect on other cell functions.
Native CAT proteins are indistinguishable
Synonymous codon substitutions can lead to a wide range of effects on the encoded protein, including changes to translational fidelity (decoding accuracy) [6] and the native structure [1, 10, 12, 17] . As a next test of the mechanism by which Shuf1 codon changes alter cell growth rate, we compared the solubility of CAT produced from the WT and Shuf1 coding sequences. In both cases, CAT was detected only in the soluble fraction of the cell lysate ( Fig.  S4a) , indicating the Shuf1 growth defect is not due to CAT aggregation. Likewise, the purified CAT proteins produced from each mRNA sequence had indistinguishable secondary and tertiary structure ( Fig. S4b) , indistinguishable resistance to chemical and thermal denaturation ( Fig. 3b, S4c ) and indistinguishable specific activity ( Fig. 3c) . We also used mass spectrometry to compare the molecular weights of CAT translated from these coding sequences. These masses were indistinguishable to within one mass unit and matched the expected molecular weight of 25,953 Da. Taken together, these results demonstrate that CAT production from the Shuf1 coding sequence does not prohibit formation of the native, active CAT structure.
Shuf1 coding sequence impairs native CAT protein production
We noticed that addition of the ssrA tag led to a larger reduction in intracellular accumulation of CAT produced from the Shuf1 versus WT coding sequence ( Fig. 2c, S4a) . To determine whether this decrease in Shuf1-CAT was due to a defect arising from Shuf1 transcription and/or mRNA half-life, we quantified the levels of WT and Shuf1 mRNA. These levels were indistinguishable ( Fig. S5a) , supporting a model where the Shuf1 synonymous codon changes affect intracellular CAT concentration at the translational level, likely due to a greater susceptibility to protein degradation.
To explore this further, we subjected native, purified ssrA-tagged CAT produced in vivo from the WT or Shuf1 coding sequences to an in vitro ClpXP degradation assay [43, 44] . Consistent with our other analyses of the native CAT structures and stabilities (above), the native proteins were equally resistant to degradation by ClpXP ( Fig. 4a) . This result suggests CAT produced from the Shuf1 mRNA sequence is more susceptible to degradation by ClpXP only prior to acquiring its native structure. Because the ssrA tag is located at the CAT Cterminus, this degradation is presumably post-translational, occurring after release of the nascent chain from the ribosome. To further test this model, we next tested (i) whether the Shuf1 growth defect was dependent on ClpXP activity in vivo and (ii) whether we could develop a physical mechanism for the impact of synonymous codon substitutions on Shuf1-CAT folding.
ClpXP preferentially degrades Shuf1-CAT folding intermediates
A prediction of the model described above is that the Shuf1 codon-dependent growth defect is exacerbated by post-translational degradation of ssrA-tagged CAT by cellular proteases, specifically ClpXP. ClpXP is the major E. coli protease responsible for degrading ssrA-tagged polypeptides under log-phase growth [43, 45] . In general, less stably-folded proteins are more susceptible to degradation by ClpXP than more stable substrates [46] [47] [48] , presumably because less energy is required to unfold unstable protein structures and expose the chains to the ClpXP protease active sites [49] . To test whether ClpXP degradation is the key mechanism impairing growth when E. coli expresses CAT from the Shuf1 coding sequence, we induced expression of WT and Shuf1 CAT in E. coli W3110, which lacks ClpX [46, 50] , and compared growth in this background to the parent strain, in the presence of cam. ClpX deletion enhanced growth only of cells expressing ssrA-tagged CAT from the Shuf1 coding sequence (Fig. 4b) .
Likewise, omission of the ssrA tag enhanced growth only for E. coli expressing ClpX; there was no effect on cells lacking ClpX (Fig. 4c) . These results confirm that the major effect of the Shuf1 synonymous codon substitutions is enhanced degradation of ssrA-tagged CAT by ClpXP.
Shuf1 synonymous codon substitutions alter the CAT folding mechanism
As the next step towards a physical mechanism for the impact of synonymous codon substitutions on Shuf1-CAT folding, we noticed that after five hours of high-level induction in the presence of cam the growth rate of cells expressing the Shuf1 mRNA sequence increased to match the growth rate of cells expressing the WT sequence ( Fig. 2b, right panel; note similar slopes at induction times >5 hr). This increase in growth rate for E. coli transformed with the Shuf1 plasmid was not due to the appearance of suppressor mutations, as cells taken from the endpoints of these growth assays had a reproducible growth lag when subsequently diluted and grown under identical conditions ( Fig. S5b) . In all of the cell growth assays described above, E. coli were induced to express CAT and at the same time challenged with cam. We hypothesized that this simultaneous challenge to both produce CAT and acetylate the antibiotic might amplify the importance of rapidly producing a sufficient pool of native CAT, highlighting the defect created by the increased susceptibility of CAT folding intermediates to degradation. Further, we hypothesized that even if only a small fraction of CAT translated from the Shuf1 coding sequence attains its native fold, the protease resistance of the native CAT structure ( Fig. 4a) will eventually lead to the accumulation of a pool of native CAT sufficient to support a WT-like growth rate, regardless of the precise folding mechanism.
A direct prediction of the hypothesis above is that providing cells with more time to accumulate native CAT prior to cam addition should reduce or eliminate the Shuf1 growth defect. To test this prediction, we modified our growth assay to induce CAT production in the overnight culture, then diluted cells into fresh growth medium in the presence of cam and inducer. Overnight induction was sufficient to suppress the Shuf1-CAT growth defect, but only when a high concentration of inducer was used ( Fig. 5 ). Based on these results, we hypothesized that (1) high levels of induction enable more copies of Shuf1 CAT to fold to its native, active structure and (2) providing more time for CAT protein folding prior to cam addition can suppress the Shuf1 growth defect. In support of these hypotheses, we found that just 30 min of induction prior to cam addition was sufficient to suppress the Shuf1 growth defect, but only at high inducer conditions ( Fig. S5c) .
mRNA secondary structural stability does not explain Shuf1 growth defect
The results above suggest the Shuf1 synonymous codon substitutions impair CAT cotranslational folding by altering the rate of translation elongation. In vitro, synonymous codons have been shown to alter elongation rate either by altering the rate of decoding [51] or by altering downstream mRNA stability, which can impede ribosome translocation [52] . In vivo, there is some evidence that stable mRNA stem-loop structures can alter the elongation rate of the ribosome [53] [54] [55] , although other studies have detected no difference [37, 56, 57] . Although the overall predicted mRNA stability of the WT and Shuf1 genes are similar, a predicted stable 3' stem-loop structure in Shuf1 is not present in the WT coding sequence (Fig. S6a) . To test whether this structure is responsible for the Shuf1 growth defect, we created chimeric mRNA sequences with only the 5', middle or 3' portion of the wild type sequence substituted with the Shuf1 sequence ( Fig. S7a ) but observed no growth defect for the chimera bearing the 3' portion of Shuf1 had no impact on growth rate (Fig. S7b) . Moreover, growth rates for these chimeras correlated more closely with the difference in relative codon usage frequencies than measures of mRNA stability (Fig. S6b) . Taken together, these results indicate that translation elongation rate differences arising from changes in codon usage frequencies is a more likely origin of the Shuf1 growth defect than changes in mRNA secondary structure.
Discussion
Most of our current understanding of protein folding mechanisms is derived from studies of small proteins that refold reversibly when diluted from chemical denaturants. However, only a small number of proteins can refold robustly in vitro, even though many more can be maintained in a stable state once extracted from the cell [24, 58, 59] . This suggests that (i) the conformations adopted early during the folding process are crucial to successful folding and (ii) the cellular environment supports the formation of early folding intermediates that are distinct from the conformations populated upon dilution from denaturant. Indeed, there is substantial evidence that molecular chaperones are crucial to the successful folding of many complex proteins in vivo [29] [30] [31] [32] . Although it has been hypothesized that synonymous codon changes could alter elongation rate and modify folding mechanisms in vivo, it has thus far been challenging to find evidence to support this hypothesis from experiments performed in vivo, possibly due to buffering provided by molecular chaperones.
Our results demonstrate that, during synthesis, the folding of nascent CAT polypeptide chains is sensitive to synonymous codon-induced changes to translation elongation rate. Although in all cases the nascent chains produced using different synonymous codon patterns remain capable of achieving the native, protease-resistant CAT trimer structure, translation of the wild type mRNA sequence led to the formation of CAT folding intermediates that are less susceptible to degradation by cellular proteases once released from the ribosome (Fig. 6) . Crucially, these results demonstrate that although the CAT native structure is indistinguishable regardless of synonymous codon usage, the folding mechanism differs significantly, leading to increased degradation and an adverse effect on cell fitness.
These results are consistent with a small but growing number of studies indicating that synonymous codon substitutions can perturb protein folding mechanisms [1, 10, 12, 60] and highlight strategies for uncovering such perturbations even when they do not alter the final protein structure. In contrast, recent in vitro single molecule force-unfolding experiments have shown that some small, ribosome-bound natively-folded domains fold via similar mechanisms on and off the ribosome [61, 62] . However, as these studies noted, forced unfolding measured by molecular tweezers cannot capture the transient folding of a nascent chain during its synthesis, and hence what is measured in these experiments is the effect of close proximity of the ribosome surface, rather than co-translational folding. The very robust folding behavior of these well-characterized, reversible folding models may indeed lead to indistinguishable folding behavior during translation, a model supported by recent force-feedback folding measurements [63] . Of note, the model proteins selected for these studies are smaller than >75% of proteins in the E. coli proteome [24] , whereas all known examples of synonymous codon-derived alterations to co-translational folding are much larger (e.g., [1, 9, 10, 64] ). We are not aware of an in vitro folding mechanism for a protein >175 aa long that is preserved during co-translational folding.
Our CAT results demonstrate that synonymous changes to mRNA coding sequences can significantly perturb folding of the wild type protein sequence even in the presence of its repertoire of relevant molecular chaperones. This result suggests that mRNA sequences have likely evolved alongside molecular chaperones to most efficiently support folding of the broad repertoire of protein structures produced in vivo. Although our understanding of co-translational folding mechanisms is still in its infancy, these results imply that it should ultimately be possible to rationally design mRNA coding sequences in order to enhance co-translational folding and to identify disease-associated synonymous codon substitutions most likely to adversely affect protein folding, particularly for large or otherwise complex proteins.
Methods
Cell growth assays
A single colony of E. coli KA12 [66] or W3110 [50] transformed with a pKT-CAT plasmid from a freshly streaked LB-amp plate was used to inoculate 20 mL of LB plus 100 μg/mL ampicillin (LB-amp) and grown overnight with shaking at 37°C. Unless otherwise specified, all cultures contained 100 μg/mL ampicillin and no tetracycline. Overnight cultures were used to innoculate fresh LB-amp to an optical density at 600 nm (OD600) of 0.05, to which was added 35 μg/mL chloramphenicol (unless otherwise specified) and the indicated concentration of tetracycline inducer (0-1600 ng/mL), transferred to one well of a 12-well plate and incubated at 37°C with continuous shaking in a Synergy H1 microplate reader (BioTek). Growth was measured as the increase in OD600. The linear portion of the growth curve was fit to a straight line and the slope was taken as the growth rate. In the ClpX deletion strain (W3110 ΔclpX), a large increase in growth rate relative to the parent strain is observed only for ssrA-tagged Shuf1. Other constructs grow slightly slower in the absence of ClpX. U, uninduced cell culture. (C) Impact on growth rate of removing the ssrA tag. Omitting the ssrA tag has no effect on growth in the ClpX knockout (hatched bars). In the presence of ClpX (solid bars), there is a much larger increase in growth upon ssrA tag deletion for Shuf1 than WT, indicating Shuf1 is more susceptible to ClpXP degradation than WT. Data points represent the mean ± SD; n=3 biological replicates. To whom correspondence should be addressed: pclark1@nd.edu 01-574-631-8353
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Synonymous CAT coding sequence design
The Shuf1 synonymous mutant sequence was designed using a Monte Carlo algorithm. The first 46 codons (excluding the His tag) were left unchanged to avoid altering translation initiation [5, [37] [38] [39] [40] . For remaining amino acid positions, a synonymous codon was chosen at random. After each random sequence was designed, its codon usage frequencies were analyzed using the %MinMax algorithm [18, 36] , which compares the codon usage frequency of a coding sequence to hypothetical sequences that encode the identical amino acid sequence using either the most common (+100%) or most rare (-100%) codons possible. This simple algorithm has been shown to accurately predict the relative effects of synonymous codon changes on elongation rate [10, 19] . The %MinMax codon usage profile of each synonymous sequence was compared to the WT profile. Profiles were filtered to select those with the same number of 17-codon windows of rarer-than-average codon usage, a sequence-wide average codon usage very similar to the wild type mRNA sequence (%MinMax within +/-3% of WT), and likewise very similar extreme codon usage values (maximum and minimum %MinMax values within +/-5% of WT). Out of one million sequences generated, three fulfilled these criteria. The coding sequence with the lowest Pearson correlation coefficient compared to WT was chosen as Shuf1.
Molecular biology
All CAT constructs were synthesized by GeneArt (Invitrogen). The pKT and pKTS plasmids were a generous gift from Donald Hilvert (ETH, Zurich). CAT constructs were cloned into pKT and pKTS using FastCloning [65] . All primers were ordered from IDT as standard desalting primers and resuspended to 1 mg/mL in ddH2O. pKT and pKTS were amplified using primers pKT F (ACTAGTGCGGCCGCTTGATAAA) and pKT R (ATGTATATCTCCTTCTTAA AGTTAAACAAAATTATTTCTAGAGGGAAA) and pKTS F (GCGGCGAACGATGAAAACTATG C) and pKT R, respectively. The CAT F primer (AGAAGGAGATATACATATGCATCACC ATCACCATCACCATAACTATACAAAATTTG) was used to amplify all CAT constructs. Unique primers were required for the reverse direction. WT R pKT (AAGCGGCCGCACTAGTTTATTTTAATTTA CTGTTACACAACTCTTGTAG) was used to clone WT and the common variant of CAT [11] into pKT, WT R pKTS (TTTCA TCGTTCGCCGCTTTTAATTTACTGTTACACAACTCTTGTAGCCGATTAATAAAGC) for pKTS, Shuf1 R pKT (AAGCGGCCGCACTAGTTTACTTCAATTTAGAATTACATAACT CCTGTAAT) was used to clone Shuf1 CAT into pKT, and Shuf1 R pKTS (TTTCATCGTTCGCCGCCTTCAATTTAGAATTACATAACTCCT GTAATCTGTTAATGAAGC) for pKTS.
To make the chimeric CAT constructs, the 5', center or 3' region of the Shuf1 coding sequence were amplified and cloned into the WT CAT sequence. All hybrid CAT constructs were cloned into pKTS. Primers were ordered from IDT as standard desalting primers. To make the 5' chimera, the WT plasmid was amplified using the primers WTsN F (GCTATCCTGCCCC TATTCATCCGATATTGATCAATTTATGGTGAATTATTTATCGGT) and WTsN R (ATATCATCA CGGGGTAAAACTTATACGCTGAATCATCCAATGACTTTTTTAACGTC) and codons 58-111 of Shuf1 using the primers Shuf1 N F (TACCCCGTGATGATATACTTAATTGCCCA) and Shuf1 N R (ATAGGGGCAGGATAGCGCAC). To make the middle chimera, the WT plasmid was amplified using the primers WTsM F (TGACTATTTTGCGCCGATTATAACAATGGCAAAATAT CAGCAAGAAGGG) and WTsM R (GATCGATGTCCGAGCTGTATGGGCAACTCAGTGCTGAA AA) and codons 112-172 of Shuf1 using the primers Shuf1 M F (AGCTCGGACATCGATCAAT TTATGG) and Shuf1 M R (CGGCGCAAAATAGTCAGTAAAGTTAGCTA). To make the 3' chimera, the WT plasmid was amplified using the primers WTsC F (TAATTCTAAATTGAAGG CGGCGAACGATGAAAACTATGC) and WTsC R (TGGCCATGGTTATGATGGGTGCAAAATA ATCGGTAAAATTAGCAA) and codons 173-220 of Shuf1 using the primers Shuf1 C F (ATCAT AACCATGGCCAAATACCAACAG) and Shuf1 C R (CTTCAATTTAGAATTACATAACTCCTGT AATCTGTTAATGAAGC).
PCR reactions were prepared using 5 μL of supplied 10x PfuUltra II buffer (Agilent), 2.5 mM dNTPs (AMRESCO), 2 ng/μL of forward and reverse primer, 0-3 mM MgCl2, 0.2 ng/μL DNA, and 1 μL PfuUltra II Fusion HS DNA polymerase (Agilent). The total reaction volume was 50 μL. The PCR protocol started with 2 min at 95°C followed by 18 cycles of: 95°C for 30 sec, Tm-5°C for 1 min, 72°C for 2.5 min, then a final step of 72°C for 10 min.
PCR products were treated with 1 μL DpnI for 1.5 hours at 37°C. The insert and vector were then mixed together in 1:1, 1:2, 1:4, 2:1, and 4:1 ratios and 10 μL were incubated with 100 μL chemically competent E. coli DH5α for 30 min on ice. Cells were heat shocked at 42°C for 45 sec, incubated on ice for 2 min, and recovered at 37°C with 500 μL of SOC media (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose) for 1 hr. The entire transformation reaction was spread on an LB-agar plate with 100 μg/mL ampicillin and incubated overnight at 37°C. Single colonies were grown in liquid culture and DNA was extracted (Wizard Plus minipreps, Promega) using the manufacturer's directions. The entire gene along with its promoter and transcription terminator was sequenced.
CAT protein purification
To purify CAT for in vitro analyses, 1 L cultures were inoculated as above with 1600 ng/mL tetracycline. Cultures were grown at 37°C with continuous shaking for 6.5 hours. Cells were pelleted at 4,000xg for 15 min and resuspended in nickel affinity binding buffer (500 mM NaCl, 20 mM imidazole, 20 mM sodium phosphate pH 8). Cells were lysed by repeated cycles of freezing at -80°C for 30 min followed by thawing at room temperature. Lysozyme (final concentration 1 mg/mL) was added after the first freezing cycle. Thawed lysates were incubated for 30 min at 4°C with frequent inversions to facilitate lysis. In total, cells were frozen and thawed four times. After lysis, cells were homogenized with 25 mM MgCl2 and 80 μL DNase I (Invitrogen). The lysates were again incubated at 4°C for 30 min with frequent inversions. Alternatively, lysates were homogenized by sonication for 12 min using 30 sec on 30 sec off. After lysis, the lysate was pelleted at 14,000xg for 15 min and CAT was purified from the supernatant using nickel affinity chromatography (His Spin Trap (small volumes), HisTrap HP (large volumes); GE Healthcare). After addition of the cell supernatant, columns were washed with binding buffer and eluted with elution buffer (500 mM NaCl, 500 mM imidazole, 20 mM sodium phosphate pH 8). CAT protein concentration was determined by absorbance at 280 nm, using a calculated CAT extinction coefficient of 30,350 (for His-CAT) or 31,630 M -1 cm -1 (for His-CAT-ssrA) [67] .
Far-UV circular dichroism spectroscopy
Far-UV CD spectra were collected using a J-815 CD Spectropolarimeter (JASCO). CAT protein samples were diluted to a concentration of 4 μM in 20 mM phosphate buffer pH 8. Three spectra were collected from 190-250 nm with a 1 second integration time and a 2 nm bandwidth, averaged and from this an averaged spectrum of the blank buffer solution (collected under identical conditions) was subtracted. The effect of increasing temperature on the far-UV CD spectrum was recorded every 2°C from 4-95°C. Samples were equilibrated for 2 min at each temperature prior to data collection. To normalize the spectra, the average signal prior to and after the unfolding transition were set to 100% and 0% folded, respectively.
Tryptophan fluorescence emission spectroscopy
Purified CAT protein was diluted to 2 μM and incubated overnight in 100 mM Tris buffer pH 7.5 with 0-4 M guanidinium HCl at 4°C. Tryptophan emission spectra were collected using a PTI QM-6 fluorimeter (Birmingham, NJ). An excitation wavelength of 280 nm was used (2 nm slit widths) and emission was measured from 300-380 nm (4 nm slit widths; 3 sec integration time). To normalize the spectra, the average fluorescence emission intensity prior to and after the unfolding transition were set to 100% and 0% folded, respectively. The resulting curves were then fit to a sigmoidal function.
Acetyltransferase activity assay
CAT enzymatic activity was measured as described previously [68] . Briefly, CAT was diluted to a concentration of 6.25 μg/mL in 1 mL of reaction mix (94 mM Tris pH 7.8, 83 μM DTNB, 190 μM acetyl-CoA and 155 μM chloramphenicol). Free CoA-SH produced by the CAT reaction subsequently reacts with DTNB to make TNB, which absorbs at 412 nm. Absorbance at 412 nm was monitored for 5 min in a DU 530 UV-Vis Spectrophotometer (Beckman Coulter).
To determine the specific activity from these curves, the initial velocity of the reaction was calculated by fitting data points from 0.25-1 min to a straight line. The initial velocity was divided by the extinction coefficient for TNB (0.0136 μM -1 cm -1 ) to convert to units of enzyme activity and the amount of CAT to calculate activity in units per microgram. One unit of activity converts 1 nmol of chloramphenicol and acetyl-CoA to chloramphenicol-3-acetate and CoA per min. The average activity of WT His-CAT was set to 100%; results for other CAT proteins were normalized to this value.
Mass spectrometry
The molecular weight of CAT was measured using HPLC-ESI-MS as described previously [69, 70] , with minor modifications. Briefly, purified CAT was diluted to 0.5 mg/mL in 25 mM ammonium bicarbonate pH 8.0 and 5 µg was injected per sample. A 20 min gradient from 10-80% A-B (A: H2O, 0.1% formic acid; B: acetonitrile, 0.1% formic acid) with the first 3 min diverted to waste was performed. Positive mode electron spray ionization was acquired on a micro TOF-QII (Bruker, Billerica, MA) mass spectrometer with 2 sec spectral averaging. The MaxEnt software package (Bruker) was used for deconvolution. The deconvoluted mass measured for each CAT variant was 25,953 Da, identical to the predicted mass. E. coli expressing WT or Shuf1 His-CAT-ssrA were grown to an OD600 of 0.3 at 37°C in LB with amp and induced with 1000 ng/mL tc for 3 hr. Cells (from 10 mL cultures) were pelleted at 4,000xg for 15 min and stored at -80°C. Cell pellets were lysed using a bead mill (BioSpec OK, USA) 3 x 30 sec in 1% SDS 100 mM ammonium bicarbonate (ABC) and clarified by centrifugation at 12,000xg for 10 min. Whole cell protein lysates were quantified by BCA assay (Thermo Scientific) according to the manufacturer's instructions.
Whole cell lysates were prepared for proteomics as previously described [71] , with minor modifications. All reagents were from Sigma unless otherwise described. First, 50 µg of each lysate was suspended in 5% SDS 100mM ABC and reduced and alkylated with dithiothreitol and iodoacetamide. Samples were then digested with trypsin using Strap columns (Protifi, NY) according to manufacturer's instructions, with the following alterations. Mass-spectrometry grade trypsin (Promega, WI) was added at 1:40 (m/m) and digested overnight at 37°C. Peptides were eluted from the digestion column and desalted using a 10 mg HLB SPE column (Waters, MA) following the manufacturer's recommended conditions. Desalted peptide digests were dried and stored at -20°C until LC/MS/MS analysis.
Each digested sample (1 µg) was analyzed in triplicate using LC-MS/MS with a Waters nanoUHPLC Acquity (Billerica, MA) and a Q-Exactive Oribitrap (Thermo, San Jose, CA). RAW files from the Nano UHPLC-MS/MS acquisition were subjected to tandem spectral match and quantification using label free quantification [72] . The current KA12 E. coli proteome (UP000000625) concatenated with the WT/Shuf1 His-CAT-ssrA sequences and common contaminants was used to assign peptides. Data were normalized using median fold change.
Calculation of local mRNA secondary structure
A sliding window analysis was used to predict local stable structure in overlapping 30 ntlong segments of the CAT coding sequence, using the Quikfold algorithm to calculate the free energy of mRNA folding [73] . All predicted stable structures were plotted.
Correlation between growth and mRNA properties
Growth was calculated as the %WT OD600 after 4 hours of growth in cam. The change in %MinMax was calculated by summing the absolute value of the differences between a given construct and WT. This number was divided by the average %MinMax of the gene as a proxy for protein production. The strongest local mRNA secondary structure element per gene was calculated as above. These data were fit to a line using Prism.
Western blotting
Cultures were inoculated as described above and induced for 6.5 hours. Aliquots were pelleted at 14,000xg for 15 min and the cell pellets were resuspended to an OD600 of 15 in 100 mM Tris pH 7.5. To this was added one half-volume of 3x SDS gel loading buffer and βmercaptoethanol (BME) to 5 mM. Samples were boiled for 40 min, separated using denaturing polyacrylamide gel electrophoresis, transferred to a PVDF membrane and probed using a mouse anti-His antibody (Promega) and goat anti-mouse secondary antibody conjugated to alkaline phosphatase. In some experiments, the 7x-His tag was replaced with an HA tag (YPYDVPDYA) and the primary antibody used was rabbit α-HA (Sigma). Intensities of CAT protein bands were quantified using ImageJ.
mRNA quantification
Cultures were inoculated as described above and grown for 2.5 hr until the cells achieved an OD600 of about 0.3. RNA was purified using the RNeasy kit (Qiagen), according to manufacturer protocol. RNA concentrations were determined by absorbance at 260 nm. Purified RNA was stored at -80°C.
RNA samples were treated with DNase to remove genomic DNA or plasmid contaminants. To 10 μL of RNA (about 0.2 μg) 10 μL of DNase buffer (10 mM Tris pH 7.5, 2.5 mM MgCl2, 0.5 mM CaCl2) was added with 2 units of RNase-free DNase (Ambion/Invitrogen).
Samples were incubated at 37°C for 30 min, then 1 μL of 100 mM EDTA was added and samples were incubated at 65°C for 10 min to denature the DNase. Reverse transcription (RT) was performed using the iScript RT kit (BioRad). RNA was diluted to about 100 ng/μL into RT reaction mix (20 μL total, 4 μL 5x buffer, 2 μL random hexamer primers, 1 μL reverse transcriptase). Control reactions lacking RT were used to ensure the PCR amplification was specific for mRNA. To perform the RT, the following protocol was used on a MyCycler (BioRad): 5 min at 25°C, 30 min at 42°C, 5 min at 85°C. The resulting cDNA was diluted fivefold for quantitative PCR (qPCR) in a 96 well plate using a CFX96 Touch Real-Time PCR Detection System (BioRad). The reaction volume was 5 μL and included 1 μL of cDNA, 60 nM primers (IDT) and 2.5 μL SsoAdvanced SYBR Green Supermix (BioRad). To amplify all CAT constructs the primers CAT qPCR F (CCATCACCATAACTATACAAAATTTGATGTAAAAAATT) and CAT qPCR R (AAACTTATACGCTGAATCATCCAATGA) were used. To amplify E. coli GAPDH, the primers GAPDH qPCR F (CGGTACCGTTGAAGTGAAAGAC) and GAPDH qPCR R (ACCAGTTGCTTCAGCGAC) were used. ΔCT values were calculated by taking the difference in CT values for each CAT construct with its corresponding GAPDH CT. ΔΔCT values were calculated by taking the difference in ΔCT from WT CAT. This was converted to fold change in RNA level by raising 2 to the power of -ΔΔCT.
Growth rate as function of induction time
Cultures were inoculated as described above in 20 mL of LB with amp and grown in shake flasks at 37°C. Cultures were grown to an OD600 of ~0.35 at 37°C and induced with 1600 ng/mL tc. Cells were induced from 0-60 min. Then a 1 mL aliquot was pelleted at 21,000xg for 5 min and resuspended in LB with amp and cam. These were diluted twofold into a 24 well plate. Growth was monitored with double orbital shaking for 5 hours. Growth from 1-3 hours after chloramphenicol addition was fit to a line and the slope was used as the growth rate. Growth rates were normalized to the average growth rate of both constructs after 60 min induction.
ClpX knockout effect on growth
The ClpX knockout was in the E. coli W3110 background. Knockout and parent strain were cultured as described above. These strains were induced with 50 ng/mL tc. The effect of ClpX or ssrA tag on growth was calculated by dividing the endpoint OD600. No effect of deletion would render a value of 1.
Contact maps
Contact maps were generated using VMD software support and the crystal structure of CATIII (PDBID: 3CLA) [33] . VMD was developed with by the Theoretical and Computational Biophysics group at the Beckman Institute, University of Illinois at Urbana-Champaign.
ClpXP degradation assay
ClpXDN3 or ClpP were overexpressed in E. coli and purified using Ni 2+ affinity and size exclusion chromatography, as described previously [74] . ClpXP degradation were performed in PD buffer (25 mM HEPES pH 7.6, 100 mM KCl, 10 mM MgCl2, 10% v/v glycerol, 2 mM BME at 30°C. CATssrA purified as above (2 µM) was incubated with 300 nM ClpX6 (as 600 nM ClpXDN3), 900 nM ClpP14, 5 mM ATP (Sigma), 0.2 mg/ml creatine phosphokinase (CPK, Sigma), and 1.6 mM creatine phosphate (Sigma). At indicated timepoints, an aliquot of the degradation reaction mix was removed and combined with SDS-PAGE loading dye. The degradation reaction was monitored by SDS-PAGE.
Figure S1
The native CAT structure is very thermostable but cannot be refolded after chemical denaturation. (A) CAT activity, expressed as the change in absorbance of TNB over time in the presence of native or refolded CAT (see Methods). Refolded CAT does not have significant acetyltransferase activity. (B) Thermal denaturation of native, purified CAT, monitored as the change in the far-UV CD signal at 205 nm; n=3, data are represented as mean ± SD.
Figure S2
The C-terminal ssrA tag does not affect properties of native, purified CAT, but does affect chloramphenicol resistance of E. coli expressing CAT from the Shuf1 coding sequence. (A) Growth curves for cell expressing CAT codon variants without an ssrA tag. (B) Far-UV CD spectra of CAT and CAT-ssrA. (C) Thermal denaturation of CAT and CAT-ssrA monitored by changes in the far-UV CD signal at 205 nm. (D) Acetyltransferase activity of CAT and CAT-ssrA are indistinguishable; p=0.12, Welch's t-test; n=3, data are represented as mean ± SD. (E) E. coli were induced to express CAT from the WT or Shuf1 coding sequence for 5 hr and then tested for minimum inhibitory concentration of chloramphenicol (cam). Kr TTG CCG CTC TCA GTA CAG GTT CAT CAT GCA GTT TGT GAT GGC TTC CAT GTT  Sh TTA CCC TTG AGC GTC CAG GTG CAT CAC GCC GTG TGT GAC GGC TTT CAT GTT 205 Ala-Arg-Phe-Ile-Asn-Arg-Leu-Gln-Glu-Leu-Cys-Asn-Ser-Lys-Leu-Lys- Ala-WT GCA CGC TTT ATT AAT CGG CTA CAA GAG TTG TGT AAC AGT AAA TTA AAA GCG  Kr GCA CGC TTT ATT AAT CGG CTA CAA GAG TTG TGT AAC AGT AAA TTA AAA GCG  Sh GCA CGC TTC ATT AAC AGA TTA CAG GAG TTA TGT AAT TCT AAA TTG AAG GCG 222 Ala-Asn-Asp-Glu-Asn-Tyr-Aal-Leu-Ala-Ala-*** WT GCG AAC GAT GAA AAC TAT GCG CTG GCG GCG TAA Kr GCG AAC GAT GAA AAC TAT GCG CTG GCG GCG TAA Sh GCG AAC GAT GAA AAC TAT GCG CTG GCG GCG TAA
Figure S3
CAT coding sequences used in this study. Codon substitutions are highlighted. WT, wild type CAT; Kr, synonymous variant described previously [11] ; Sh, Shuf1 synonymous variant.
Figure S4
The native CAT protein structures expressed from the WT, Komar [11] and Shuf1 coding sequences are indistinguishable. (A) Partitioning of CAT-ssrA into soluble (sup) and insoluble (pellet) cell lysate fractions. (B) Far-UV CD spectra. (C) Guanidinium hydrochloride denaturation of CAT monitored as change in ratio of tryptophan fluorescence emission intensity at 330 versus 349 nm; n=3, data are represented as mean ± SD.
Figure S5
(A) Fold change in CAT mRNA levels relative to WT, as determined by RT-qPCR. (B) Growth curves of cells taken from the endpoint of a growth curve expressing Shuf1-CAT in cam compared to initial growth curves, with or without induction of CAT. (C) Growth rate of cells expressing CAT from the WT or Shuf1 coding sequences with varying induction time prior to addition of cam. More time is required to produce a sufficient amount of native CAT to support growth in the presence of cam when CAT expressed from the Shuf1 versus WT coding sequence; n=3 biological replicates, data are represented as mean ± SD.
Figure S6
Growth defect correlates with codon usage and not mRNA structure or GC content. A) mFold predictions of local mRNA secondary structure over 30 nt windows. Background color indicate chimera construct boundaries. B) Correlation between change in %MinMax divided by the average %MinMax, strongest local mRNA secondary structure element, and %GC with growth. Growth is plotted as the %WT OD600.
